This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Qvisth, V. Articles by Bolinder, J. Search for Related Content PubMed PubMed Citation Articles by Qvisth, V. Articles by Bolinder, J.

Combined Hyperinsulinemia and Hyperglycemia, But Not Hyperinsulinemia Alone, Suppress Human Skeletal Muscle Lipolytic Activity in Vivo

Departments of Medicine (V.Q., E.H.-T., S.S., J.B.) and Vascular Surgery (S.E.), Karolinska University Hospital-Huddinge, Karolinska Institute, S-141 86 Stockholm, Sweden; and Department of Internal Medicine (R.S.S.), Section of Endocrinology, Yale University School of Medicine, New Haven, Connecticut 06520

Address all correspondence and requests for reprints to: Dr. Jan Bolinder, Department of Medicine, M 63, Karolinska University Hospital-Huddinge, S-141 86 Stockholm, Sweden. E-mail: jan.bolinder{at}hs.se.

Effects of circulating insulin and glucose concentrations on skeletal muscle and adipose tissue lipolytic activity were investigated in 10 type 1 diabetes patients with no endogenous insulin secretion. Microdialysis measurements of interstitial glycerol and determination of fractional glycerol release were carried out during standardized combinations of relative hypoinsulinemia/moderate hyperglycemia (11 mmol/liter), hyperinsulinemia/ normoglycemia (5 mmol/liter), and hyperinsulinemia/moderate hyperglycemia, respectively. Local tissue blood flow rates were measured with the ¹³³Xe clearance technique. In response to the change from hypo- to hyperinsulinemia, the fractional release of glycerol decreased from 159.6 ± 17.8 to 85.1 ± 13.7 µmol/liter (P < 0.0001) in adipose tissue, whereas it remained unchanged in skeletal muscle (44.6 ± 6.4 vs. 36.0 ± 7.4 µmol/liter; not significant). When hyperinsulinemia was combined with hyperglycemia, fractional glycerol release was further reduced in adipose tissue (64.5 ± 12.2 µmol/liter; P < 0.05), and in this situation it was also markedly decreased in skeletal muscle (18.1 ± 4.8 µmol/liter; P < 0.0001). Skeletal muscle blood flow was unaltered over the respective study periods. Adipose tissue blood flow decreased by 50% in response to hyperinsulinemia (P < 0.0005), but no further change was seen when hyperinsulinemia was combined with hyperglycemia. It is concluded that in patients with type 1 diabetes, insulin does not exert an antilipolytic effect in skeletal muscle during normoglycemia. However, in response to combined hyperinsulinemia and hyperglycemia, the lipolytic activity in skeletal muscle is restrained in a similar way as in adipose tissue. This may be explained by a glucose-mediated potentiation of the antilipolytic effectiveness of insulin.

This article has been cited by other articles:

				A. L. Birkenfeld, P. Budziarek, M. Boschmann, C. Moro, F. Adams, G. Franke, M. Berlan, M. A. Marques, F. C.G.J. Sweep, F. C. Luft, et al. Atrial Natriuretic Peptide Induces Postprandial Lipid Oxidation in Humans Diabetes, December 1, 2008; 57(12): 3199 - 3204. [Abstract] [Full Text] [PDF]

				J. W.E. Jocken, C. Roepstorff, G. H. Goossens, P. van der Baan, M. van Baak, W. H.M. Saris, B. Kiens, and E. E. Blaak Hormone-Sensitive Lipase Serine Phosphorylation and Glycerol Exchange Across Skeletal Muscle in Lean and Obese Subjects: Effect of {beta}-Adrenergic Stimulation Diabetes, July 1, 2008; 57(7): 1834 - 1841. [Abstract] [Full Text] [PDF]

				G. A. Wallis, A. L. Friedlander, K. A. Jacobs, M. A. Horning, J. A. Fattor, E. E. Wolfel, G. D. Lopaschuk, and G. A. Brooks Substantial working muscle glycerol turnover during two-legged cycle ergometry Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E950 - E957. [Abstract] [Full Text] [PDF]

				C. S. Chaurasia, M. Muller, E. D. Bashaw, E. Benfeldt, J. Bolinder, R. Bullock, P. M. Bungay, E. C. M. DeLange, H. Derendorf, W. F. Elmquist, et al. AAPS-FDA Workshop White Paper: Microdialysis Principles, Application, and Regulatory Perspectives J. Clin. Pharmacol., May 1, 2007; 47(5): 589 - 603. [Full Text] [PDF]

				V. Qvisth, E. Hagstrom-Toft, S. Enoksson, E. Moberg, P. Arner, and J. Bolinder Human Skeletal Muscle Lipolysis Is More Responsive to Epinephrine Than to Norepinephrine Stimulation in Vivo J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 665 - 670. [Abstract] [Full Text] [PDF]

				E. Bernroider, A. Brehm, M. Krssak, C. Anderwald, Z. Trajanoski, G. Cline, G. I. Shulman, and M. Roden The Role of Intramyocellular Lipids during Hypoglycemia in Patients with Intensively Treated Type 1 Diabetes J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5559 - 5565. [Abstract] [Full Text] [PDF]

				S. W. Coppack, D. L. Chinkes, J. M. Miles, B. W. Patterson, and S. Klein A Multicompartmental Model of In Vivo Adipose Tissue Glycerol Kinetics and Capillary Permeability in Lean and Obese Humans Diabetes, July 1, 2005; 54(7): 1934 - 1941. [Abstract] [Full Text] [PDF]